Skip to content

Technology-Assisted Prescription Opioid Safety Education

Technology-Assisted Prescription Opioid Safety Education (T-POSE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04918446
Acronym
T-POSE
Enrollment
96
Registered
2021-06-08
Start date
2018-03-29
Completion date
2019-02-13
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use

Keywords

Non-Medical Prescription Opioid Use

Brief summary

This study will develop a technology-based brief educational intervention for hospitalized patients that will be discharged with an opioid prescription. The Investigators will conduct a small randomized clinical trial of T-POSE to determine whether it improves patients: knowledge and reduces the incidence of Non-Medical Prescription Opioid Use (NMPOU).

Detailed description

Non-medical use of prescription opioids (NMPOU) can be generally defined as not taking opioids as prescribed, which could occur unintentionally or intentionally. In 2014, 4.3 million adults in the United States (U.S.) were estimated to engage in NMPOU (Center for Behavioral Health Statistics and Quality 2014). Some patients may take a dose more frequently than prescribed because they were not receiving adequate pain relief from the prescribed dosage. While others may continue to take opioids longer than prescribed because their pain is persistent and/or they like the euphoric effects of opioids. According to a recently released Truven Health Analytics-NPR Health Poll, the majority (57%) of Americans have taken a prescription opioid and 35% of those had concerns (e.g., addiction, effectiveness, side effects) about prescription opioids. These findings suggest that while Americans are aware, some even concerned, of the potential dangers associated with prescription opioids that their utilization patterns continue to increase (Boddy 2017). Because opioids are prescribed by a physician, patients may believe that these medications are safe and they may be unaware of the risks associated with misuse and abuse of opioids. NMPOU may lead to increased risk of drug overdose, addiction, diversion and use of heroin. Many individuals with opioid use disorders initiated NMPOU before transitioning to heroin (Banerjee et al. 2016; Cerda et al. 2015) and report that their first exposure to an opioid was prescribed by a physician. This underscores the need for empirically-tested educational interventions that can potentially reduce NMPOU and diversion. Prescription opioids have an important role to play in health care and blanket policies to restrict access to prescription opioids are not appropriate, rather the hypothesis is that harm can be reduced by fundamentally changing our approach to opioid medication safety.

Interventions

OTHERT-POSE

Tablet based education and videos on opioid safety, use, and storage/disposal of the drug.

OTHERUsual Care

Printed instruction sheets on prescribed opioid.

Sponsors

West Virginia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

A small pilot study using a randomized clinical trial of T-POSE compared to usual care.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Phase I Inclusion Criteria: * Subject is being discharged from the hospital with a prescription opioid * English Speaking * Willing and able to use a tablet Phase II Inclusion Criteria: * Willing and able to provide informed written consent * Subject is being discharged from the hospital with a prescription opioid * English Speaking * Willing and able to use a tablet

Exclusion criteria

* Visual or hearing impediment that would inhibit communication with the Study Pharmacist and use of the laptop * Cognitive or mental state prohibiting informed consent * Patient reported opioid use disorder

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of Non-Medical Use of a Prescription OpioidUp to 90 days post interventionSelf report of Yes or No to follow up questions about prescription opioid use. Yes= occurrence of Non-Medical Use of a Prescription Opioid.

Secondary

MeasureTime frameDescription
Occurrence of retention of knowledge on how to safe use of prescription opioidsUp to 90 days post interventionThe number of times that a patient reports retention of materials presented.
Number of patients reporting patient satisfactionUp to 90 days post interventionOverall number of subjects satisfied with T-POSE, as measured by a 5-point Patient Satisfaction questionnaire.
Reasons for non-medical use of prescription opioidsUp to 90 days post interventionInvestigators recorded reasons for non-medical us of prescription opioids.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026